Navigation Links
Plexus Announces Expansion in Hangzhou, China
Date:9/3/2008

NEENAH, Wis., Sept. 3 /PRNewswire-FirstCall/ -- Plexus Corp. (Nasdaq: PLXS) announced today that it intends to begin manufacturing in Hangzhou, China and has entered into an agreement to lease approximately 106,000 square feet in the Binjiang Hi-Tech Park located in Hangzhou. The new facility will allow Plexus to better serve global customers with regional decision centers in the greater Shanghai area, and will further Plexus' ability to deliver a lowest total cost value proposition. This location will be the third for Plexus in Asia, adding to the current footprint in Xiamen, China and Penang, Malaysia. This expansion brings Plexus' total footprint in Asia to approximately 948,000 square feet. Production is expected to begin late in the first quarter of fiscal 2009.

Mr. Y.J. Lim, Regional President - Plexus Asia Pacific, stated, "Our facilities in Asia are integral components of Plexus' global manufacturing and supply chain solution sets. Having proximity to customers and the supply chain in the greater Shanghai area will allow us to support our future growth prospects in this region. It will also provide us with greater opportunity to tap into the broad availability of technical talent from the strong education system in the Hangzhou area, setting the stage for future growth in our engineering services offering."

Mr. Dean Foate, President and CEO, further commented, "We are pleased to announce this further expansion in China, an outcome to our strategic planning process to proactively align our footprint to meet the future needs of customers. This investment is aligned with our value proposition to deliver intelligent, profitable growth as we continue our vision to be the best EMS company in the world at serving customers with products in the mid-to-low-volume, higher-mix segment of the market."

About Plexus Corp. -- The Product Realization Company

Plexus (http://www.plexus.com) i
'/>"/>

SOURCE Plexus Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T.
2. Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T.
3. Anesiva Announces Conference Call and Webcast to Discuss Updates to Corporate Strategy and Milestones
4. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
5. Atrial Fibrillation Month - StopAfib.org Announces September Focus on Life-Threatening Irregular Heartbeat
6. Oncothyreon announces prioritization plan for development programs
7. /R E P E A T -- Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours/
8. Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.
9. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
10. Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
11. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...DO recently announced that Dr. Dominique Hebrault ...ocess Analytical Technology (PAT) in Green Chemist...9. , (PRWEB) November 20,...l Technology (PAT) in Green Chemistry and Green En...al Technology (PAT) case studies will be presented...
(Date:11/19/2009)...Nov. 19 Spherix Incorpor...gy for diabetes therapy, and a provider of technic...plement, biotechnology and pharmaceutical companie...ed $6.3 million registered direct placement to ins...mmon stock and warrants to purchase up to 1,104,34...
(Date:11/19/2009)...re/ - Aegera Therapeutics Inc. announced today the... 2B study of AEG35156, a targeted antisense therap...gy indications. ,, The study, entitled "An Open...hibitor of Apoptosis (XIAP) Antisense AEG35156 Giv...arubicin in AML Following Failure of a Single Stan...
(Date:11/18/2009)...wswire/ -- Marrone Bio Innovations (MBI), a leader...on of effective and environmentally responsible pe... named an IC20 company by the Investors, Circle, t...l investing group. ,, Companies named to the IC...ts for all stakeholders, including investors, the ...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2
... States May Soon Follow, FREDERICK, Md., April 21... product reimbursement for ActiPatch(TM) for,kidne..., (Pink Sheets:,BIEL), is the maker of ActiPatch, ...which accelerates healing., Many commonly used ph...Advil, Motrin, Nuprin) and Naproxen (Aleve, Anapro...
...xchange Symbol: RVX, CALGARY, April 21 /PRNewswir... the "Company") (TSX:RVX) announced today that 948...ll automatically be extended,pursuant to the Compa...Staff Notice 2006-0001. The Company,s stock option...s would otherwise expire during a "blackout",tradi...
...AM, Mass., April 21 Thermo Fisher,Scientific Inc....e, announced,that it will present at the following...are Conference on Monday, May 5, 2008, at 4:00 ...MA., -- Bank of America Healthcare Conference on ...he Four Seasons Hotel, in Las Vegas, NV., -- Bair...
Other Biology Technology:Maryland Approves Medicaid Reimbursement for ActiPatch(R) 2Resverlogix Share Option Extension 2Thermo Fisher Scientific to Present at Upcoming Investor Conferences 2
(Date:11/19/2009)...entists are revealing the genetic instructions ins... or maize, has one of the most complex sequences o...Madison genomicist David Schwartz, who was one of ...l Science . , "The maize genome is a true maze ... troubled would-be sequencers for years," says Sch...
(Date:11/19/2009)...genetic diversity in maize, also known as corn, re... a gene map that should pave the way to significan...f food, fuel, animal feed and fiber around the wor...own as a haplotype map, charts genetic diversity a...nes of maize. The research team, led by U.S. Depar...
(Date:11/19/2009)...e,s Ross Hardison, T. Ming Chu Professor of Bioche...ep toward unraveling how regulatory proteins contr...ent and growth. Working with collaborators includi...,s Hospital of Philadelphia, they focused specific... cells (erythrocytes). These cells contain large a...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Affymetrix Reports Second Quarter 2009 Results 52465 1Affymetrix Reports Second Quarter 2009 Results 52465 2Affymetrix Reports Second Quarter 2009 Results 52465 3Affymetrix Reports Second Quarter 2009 Results 52465 4Affymetrix Reports Second Quarter 2009 Results 52465 5Affymetrix Reports Second Quarter 2009 Results 52465 6Affymetrix Reports Second Quarter 2009 Results 52465 7Affymetrix Reports Second Quarter 2009 Results 52465 8Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 1Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 2Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 3Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 4Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 5Top Hepatitis C Treatments Equally Effective 52455 1Top Hepatitis C Treatments Equally Effective 52455 2
...endan Godley of the University of Exeter, has just...ck turtles which nest in Gabon, West Africa. The r...ronghold, as pacific populations dwindle precariou...e animals, will uncover their migratory secrets an... After fitting them with satellite trackers the te...
...um scientists from The Walter and Eliza Hall Insti...e stem cell that drives the formation of all breas...ion for understanding how normal breast tissue dev...is also likely to provide clues about how breast c...herapies. , Under normal circumstances, the newly...
... a previously unrecognized role played by the gene...gen decreases production of an energy-rich molecul...ecules. ATP supplies energy the cell needs to per..., and in this way acts as the "currency" for the c... done with mouse cells genetically altered to lack...
Other Biology News:Scientist warns of threat to last stronghold of endangered turtle 2Faults in newly discovered breast stem cells may lead to tumours 2Hopkins researchers discover genetic switch that turns off an oxygen-poor cell's combustion engine 2Hopkins researchers discover genetic switch that turns off an oxygen-poor cell's combustion engine 3
5X MEGAscript® T7 Kit from Ambion
RNAimage Kit from GenHunter
Mouse Anti-Rad 51C Monoclonal Antibody, Unconjugated, Clone 2H11/6 from ABR-Affinity BioReagents
...eptide derived from the C-terminal region of the h...-expressed growth factor spinal cord-derived growt...at by one amino acid replacement. Specificity: Re...roteins. Reactivity: Human (positive controls: NT...
Biology Products: